Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
16 results:

  • 1. Circ-malat1 accelerates cell proliferation and epithelial mesenchymal transformation of colorectal cancer through regulating miR-506-3p/KAT6B axis.
    Yang FS; Gong SX; Qiu DD
    Kaohsiung J Med Sci; 2023 Sep; 39(9):862-872. PubMed ID: 37272875
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. COPA A-to-I RNA editing hijacks endoplasmic reticulum stress to promote metastasis in colorectal cancer.
    Wang SY; Zhang LJ; Chen GJ; Ni QQ; Huang Y; Zhang D; Han FY; He WF; He LL; Ding YQ; Jiao HL; Ye YP
    Cancer Lett; 2023 Jan; 553():215995. PubMed ID: 36336148
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. malat1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.
    Matuszyk J
    Mol Med; 2022 Aug; 28(1):89. PubMed ID: 35922756
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Early-stage colon cancer with high malat1 expression is associated with the 5-Fluorouracil resistance and future metastasis.
    Ak Aksoy S; Tunca B; Erçelik M; Tezcan G; Ozturk E; Cecener G; Ugras N; Yilmazlar T; Yerci O
    Mol Biol Rep; 2022 Dec; 49(12):11243-11253. PubMed ID: 35794508
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long non-coding RNA metastasis-related lung adenocarcinoma transcript 1 (malat1) forms a negative feedback loop with long non-coding RNA colorectal neoplasia differentially expressed (CRNDE) in sepsis to regulate lung cell apoptosis.
    Yue C; He M; Teng Y; Bian X
    Bioengineered; 2022 Apr; 13(4):8201-8207. PubMed ID: 35300579
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer.
    Kim M; Min YK; Jang J; Park H; Lee S; Lee CH
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34253638
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. malat1: A Promising Therapeutic Target for the treatment of Metastatic colorectal cancer.
    Uthman YA; Ibrahim KG; Abubakar B; Bello MB; Malami I; Imam MU; Qusty N; Cruz-Martins N; Batiha GE; Abubakar MB
    Biochem Pharmacol; 2021 Aug; 190():114657. PubMed ID: 34144008
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long Noncoding RNA malat1 Promotes colorectal cancer Progression by Acting as a ceRNA of miR-508-5p to Regulate RAB14 Expression.
    Zhang C; Yao K; Zhang J; Wang C; Wang C; Qin C
    Biomed Res Int; 2020; 2020():4157606. PubMed ID: 33344634
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Aberrant expression of lncRNA malat1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
    Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
    Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer.
    Lampropoulou DI; Aravantinos G; Katifelis H; Lazaris F; Laschos K; Theodosopoulos T; Papadimitriou C; Gazouli M
    Cancer Biomark; 2019; 25(2):213-221. PubMed ID: 31045514
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA malat1 in colorectal cancer cells.
    Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
    Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. malat1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in colorectal cancer Patients and Promotes Chemoresistance through EZH2.
    Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C
    Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer.
    Li Q; Dai Y; Wang F; Hou S
    Neoplasma; 2016; 63(6):977-983. PubMed ID: 27596298
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 cancer Cell Line.
    Fűri I; Kalmár A; Wichmann B; Spisák S; Schöller A; Barták B; Tulassay Z; Molnár B
    PLoS One; 2015; 10(7):e0131699. PubMed ID: 26133168
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Resveratrol inhibits invasion and metastasis of colorectal cancer cells via malat1 mediated Wnt/β-catenin signal pathway.
    Ji Q; Liu X; Fu X; Zhang L; Sui H; Zhou L; Sun J; Cai J; Qin J; Ren J; Li Q
    PLoS One; 2013; 8(11):e78700. PubMed ID: 24244343
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.